Therapeutic Drug Monitoring Market Overview (2022-2032)
[250 Pages Report] The therapeutic drug monitoring market is projected to record a CAGR of 9.7% during the forecast period, up from US$ 1.5 Billion in 2020 to reach a valuation of US$ 2.9 Billion by 2026.
Report Attributes
Details
Estimated Base Year Value (2020)
US$ 1.5 Billion
Expected Market Value (2026)
US$ 2.9 Billion
Projected Growth Rate (2022 to 2032)
9.7%
Sales of therapeutic drug monitoring are expected to rise as organ transplant surgeries are also increasing. In addition to this, demand for therapeutic drug monitoring is rising on account of the rising preference for precision medicine.
Increasing research and development in the industry is also projected to contribute to the growth of the therapeutic drug monitoring market share.
Some of the key therapeutic drug monitoring market trends promoting the demand for therapeutic drug monitoring include precision medicine, a growing field of disease treatment and prevention that considers individual differences in genes, surroundings, and lifestyles.
Precision medicine picks treatments that are completely suited to a patient's ailment and medical history. Oncology has experienced the most development, although this technique extends into all disease areas.
Cancer patients are being treated with a combination of medications based on studies of the patient's factors such as systems biology, tumor analysis, and gene expression data in the absence and presence of pharmacological disruption.
This method, which is now being tried in various situations, intends to transform pharmacotherapy in oncology and other disease areas. Therapeutic drug monitoring has the potential to make a significant contribution to the advancement of this unique approach to patient care.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Key Growth Propellers to the Therapeutic Drug Monitoring Market Share?
Therapeutic drug monitoring is a branch of clinical chemistry and clinical pharmacology which aims at maintaining the drug concentration levels in the body fluids within the particular therapeutic range. Therapeutic drug monitoring aims to refine patient care by individually adjusting the drug dosage for better outcomes.
The global therapeutic drug monitoring market showed significant growth over the last few years and is projected to grow at a robust CAGR during the forecast period.
The sales of therapeutic drug monitoring are driven by various key factors, including an ageing population with better health care services, increasing demand for genetic testing, increased government and private sector participation in therapeutic drug monitoring markets, rise in drug profiling.
There are ongoing problems with reimbursement, reduction in the hospital fields, and a weak global economy. In addition, fluctuating exchange rates further weakens the sales of therapeutic drug monitoring.
With the advancement of technology and increased incidence in the disease population, demand for therapeutic drug monitoring is rising by gaining wide acceptance as a method of choice among patients.
As a result, the sales of therapeutic drug monitoring are expected to grow at a healthy CAGR in the forecast period.
In the upcoming years, the demand for therapeutic drug monitoring will undergo a significant rise. The convergence will make these alterations of new and more stringent regulations improvements in diagnostic technologies, automation, and system engineering.
Find your sweet spots for generating winning opportunities in this market.
Which Region holds the Highest Growth Potential in the Therapeutic Drug Monitoring Market?
Depending on geographic regions, the therapeutic drug monitoring market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.
In terms of geography, North America dominates the sales of therapeutic drug monitoring, followed by Europe. During the earlier stages, market development growth rates were higher, while the market value was relatively low. The demand for therapeutic drug monitoring was growing.
As the market value and the sales of therapeutic drug monitoring started to rise, the annual growth rate declined slightly but is expected to increase again as the market develops and the advantages of therapeutic drug monitoring get appreciated in the established markets and as the techniques and products appear in the emerging market. In addition, the emerging economies have also started showing a positive inclination as the demand for therapeutic drug monitoring increases.
How is the Competitive Landscape in the Therapeutic Drug Monitoring Market?
The therapeutic drug monitoring market is currently led by Coulter, BioChem Pharmaceuticals, BioRad, OraSure Technologies, and Roche Diagnostics.
To combat the rising demand for therapeutic drug monitoring, Thermo Fisher Scientific (US) and Mindray collaborated on Clinical Chemistry Analyzers for Drugs of Abuse Immunoassays in 2021.
F. Hoffmann-La Roche (Switzerland) announced in 2020 that new diagnostics would be built in South Africa, including labs, biotech production, and office space. To improve its diagnostics offerings and increase the sales of therapeutic drug monitoring.
Implementing a personalized therapeutic drug monitoring (TDM) strategy at the time of infliximab beginning does not increase remission rates in patients with various inflammatory illnesses. As a result, companies are increasing their research to improve their sales of therapeutic drug monitoring.
The report comprises key players contributing to the therapeutic drug monitoring market share. It also consists of organic and inorganic growth strategies adopted by market players to improve their market positions. This exclusive report analyses the competitive landscape and therapeutic drug monitoring market share acquired by players to strengthen their market position.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Scope Of Report
Report Attributes
Details
Growth rate
CAGR of 9.7% from 2022 to 2032
Base year for estimation
2021
Historical data
2015 to 2020
Forecast period
2022 to 2032
Quantitative units
Revenue in US$ billion, volume in kilotons, and CAGR from 2022 to 2032
Report coverage
Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments covered
Type, technology, region
Regional scope
North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand
Country scope
USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs.
Key Segments
By Type:
Antibiotics
Anticonvulsants
Antiarrhythmic
Antineoplastic
Bronchodilators
Immunosuppressive
HIV/AIDS Drugs
By Technology:
Spectrometry
Chromatography
Electrophoresis
Proteomic Technology
By Region:
North America
Latin America
Asia Pacific
MEA
Europe
Frequently Asked Questions
What is the Growth Outlook for the Therapeutic Drug Monitoring Market?
The therapeutic drug monitoring market is predicted to register a CAGR of 9.7% during the forecast period.
Who are the Key Players in the Therapeutic Drug Monitoring Market?
Key players holding substantial therapeutic drug monitoring market share include Roche Diagnostics, Coulter, BioRad, OraSure Technologies, and BioChem Pharmaceuticals.
What is the Future of the Therapeutic Drug Monitoring Market?
As per the analysis, the therapeutic drug monitoring market share is likely to be US$ 2.9 Bn by 2026.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (No. of Tests) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Analyte
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis By Analyte, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis and Forecast By Analyte, 2022-2032
5.3.1. Analgesics
5.3.2. Antifungal
5.3.3. Antibiotics
5.3.4. Antiepileptic
5.3.5. Antineoplastic & Cancer Chemotherapy
5.3.6. Antiretroviral/Anti-HIV Drugs
5.3.7. Analeptics & Bronchodilators
5.3.8. Anti-arrhythmic Drugs
5.3.9. Antihypertensive
5.3.10. Immunosuppressive Agents
5.3.11. Psychoactive Agents
5.3.12. Addiction Therapeutics
5.3.13. Antihypertensive
5.3.14. Hormones
5.3.15. Anticoagulants
5.3.16. Antilipidemic
5.3.17. Alzheimer’s Therapeutics
5.4. Y-o-Y Growth Trend Analysis By Analyte, 2017-2021
5.5. Absolute $ Opportunity Analysis By Analyte, 2022-2032
-dive segmentation will be available in the sample on request
6. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Technique
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis By Technique, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis and Forecast By Technique, 2022-2032
6.3.1. Immunoassay
6.3.2. Mass Spectrometry
6.3.3. Other Techniques
6.4. Y-o-Y Growth Trend Analysis By Technique, 2017-2021
6.5. Absolute $ Opportunity Analysis By Technique, 2022-2032
-dive segmentation will be available in the sample on request
7. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia & Pacific
7.3.6. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Analyte
8.2.3. By Technique
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Analyte
8.3.3. By Technique
8.4. Key Takeaways
9. Latin America Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Analyte
9.2.3. By Technique
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Analyte
9.3.3. By Technique
9.4. Key Takeaways
10. Europe Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Analyte
10.2.3. By Technique
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Analyte
10.3.3. By Technique
10.4. Key Takeaways
11. East Asia Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Analyte
11.2.3. By Technique
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Analyte
11.3.3. By Technique
11.4. Key Takeaways
12. South Asia & Pacific Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Thailand
12.2.1.3. Indonesia
12.2.1.4. Malaysia
12.2.1.5. Singapore
12.2.1.6. Australia
12.2.1.7. New Zealand
12.2.1.8. Rest of South Asia & Pacific
12.2.2. By Analyte
12.2.3. By Technique
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Analyte
12.3.3. By Technique
12.4. Key Takeaways
13. MEA Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Analyte
13.2.3. By Technique
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Analyte
13.3.3. By Technique
13.4. Key Takeaways
14. Key Countries Therapeutic Drug Monitoring Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Analyte
14.1.2.2. By Technique
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Analyte
14.2.2.2. By Technique
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Analyte
14.3.2.2. By Technique
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Analyte
14.4.2.2. By Technique
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Analyte
14.5.2.2. By Technique
14.6. U.K.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Analyte
14.6.2.2. By Technique
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Analyte
14.7.2.2. By Technique
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Analyte
14.8.2.2. By Technique
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Analyte
14.9.2.2. By Technique
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Analyte
14.10.2.2. By Technique
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Analyte
14.11.2.2. By Technique
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Analyte
14.12.2.2. By Technique
14.13. India
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Analyte
14.13.2.2. By Technique
14.14. Thailand
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Analyte
14.14.2.2. By Technique
14.15. Indonesia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Analyte
14.15.2.2. By Technique
14.16. Malaysia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Analyte
14.16.2.2. By Technique
14.17. Singapore
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Analyte
14.17.2.2. By Technique
14.18. Australia
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Analyte
14.18.2.2. By Technique
14.19. New Zealand
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Analyte
14.19.2.2. By Technique
14.20. GCC Countries
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Analyte
14.20.2.2. By Technique
14.21. South Africa
14.21.1. Pricing Analysis
14.21.2. Market Share Analysis, 2021
14.21.2.1. By Analyte
14.21.2.2. By Technique
14.22. Israel
14.22.1. Pricing Analysis
14.22.2. Market Share Analysis, 2021
14.22.2.1. By Analyte
14.22.2.2. By Technique
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Analyte
15.3.3. By Technique
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Thermo Fisher Scientific Inc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Abbott
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Roche Diagnostics
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Bio-Rad Laboratories
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Sigma-Aldrich
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Beckman Coulter, Inc.
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Randox Laboratories Ltd.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. SEKISUI MEDICAL CO., LTD.
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. Chromsystems Instruments & Chemicals GmbH
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. SJK Global, LLC.
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
16.1.11. Alpha Laboratories
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.11.5.2. Product Strategy
16.1.11.5.3. Channel Strategy
17. Assumptions & Acronyms Used18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Region, 2017-2032
Table 3: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032
Table 4: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032
Table 5: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032
Table 6: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032
Table 7: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032
Table 9: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032
Table 10: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032
Table 11: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032
Table 12: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032
Table 13: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032
Table 15: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032
Table 16: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032
Table 17: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032
Table 18: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032
Table 19: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 20: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032
Table 21: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032
Table 22: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032
Table 23: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032
Table 24: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032
Table 25: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032
Table 27: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032
Table 28: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032
Table 29: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032
Table 30: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032
Table 31: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 32: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032
Table 33: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032
Table 34: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032
Table 35: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032
Table 36: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032
Table 37: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 38: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Country, 2017-2032
Table 39: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Analyte, 2017-2032
Table 40: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Analyte, 2017-2032
Table 41: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Forecast by Technique, 2017-2032
Table 42: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Forecast by Technique, 2017-2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032
Figure 2: Global Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032
Figure 3: Global Therapeutic Drug Monitoring Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Region, 2017-2032
Figure 6: Global Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032
Figure 9: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032
Figure 10: Global Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032
Figure 11: Global Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032
Figure 12: Global Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 13: Global Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032
Figure 14: Global Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032
Figure 15: Global Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032
Figure 16: Global Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032
Figure 17: Global Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032
Figure 18: Global Therapeutic Drug Monitoring Market Attractiveness by Region, 2022-2032
Figure 19: North America Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032
Figure 20: North America Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032
Figure 21: North America Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 22: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 23: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032
Figure 24: North America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 25: North America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 26: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032
Figure 27: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032
Figure 28: North America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032
Figure 29: North America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032
Figure 30: North America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 31: North America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032
Figure 32: North America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032
Figure 33: North America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032
Figure 34: North America Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032
Figure 35: North America Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032
Figure 36: North America Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032
Figure 37: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032
Figure 38: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032
Figure 39: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 40: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 41: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032
Figure 42: Latin America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 43: Latin America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 44: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032
Figure 45: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032
Figure 46: Latin America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032
Figure 47: Latin America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032
Figure 48: Latin America Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 49: Latin America Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032
Figure 50: Latin America Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032
Figure 51: Latin America Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032
Figure 52: Latin America Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032
Figure 53: Latin America Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032
Figure 54: Latin America Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032
Figure 55: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032
Figure 56: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032
Figure 57: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 58: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 59: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032
Figure 60: Europe Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 61: Europe Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 62: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032
Figure 63: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032
Figure 64: Europe Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032
Figure 65: Europe Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032
Figure 66: Europe Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 67: Europe Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032
Figure 68: Europe Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032
Figure 69: Europe Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032
Figure 70: Europe Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032
Figure 71: Europe Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032
Figure 72: Europe Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032
Figure 73: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032
Figure 74: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032
Figure 75: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 76: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 77: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032
Figure 78: East Asia Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 79: East Asia Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 80: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032
Figure 81: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032
Figure 82: East Asia Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032
Figure 83: East Asia Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032
Figure 84: East Asia Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 85: East Asia Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032
Figure 86: East Asia Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032
Figure 87: East Asia Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032
Figure 88: East Asia Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032
Figure 89: East Asia Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032
Figure 90: East Asia Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032
Figure 91: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032
Figure 92: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032
Figure 93: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 94: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 95: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032
Figure 96: South Asia & Pacific Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 97: South Asia & Pacific Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 98: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032
Figure 99: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032
Figure 100: South Asia & Pacific Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032
Figure 101: South Asia & Pacific Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032
Figure 102: South Asia & Pacific Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 103: South Asia & Pacific Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032
Figure 104: South Asia & Pacific Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032
Figure 105: South Asia & Pacific Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032
Figure 106: South Asia & Pacific Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032
Figure 107: South Asia & Pacific Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032
Figure 108: South Asia & Pacific Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032
Figure 109: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) by Analyte, 2022-2032
Figure 110: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) by Technique, 2022-2032
Figure 111: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) by Country, 2022-2032
Figure 112: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 113: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Country, 2017-2032
Figure 114: MEA Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 115: MEA Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 116: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Analyte, 2017-2032
Figure 117: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Analyte, 2017-2032
Figure 118: MEA Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Analyte, 2022-2032
Figure 119: MEA Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Analyte, 2022-2032
Figure 120: MEA Therapeutic Drug Monitoring Market Value (US$ Mn) Analysis by Technique, 2017-2032
Figure 121: MEA Therapeutic Drug Monitoring Market Volume (No. of Tests) Analysis by Technique, 2017-2032
Figure 122: MEA Therapeutic Drug Monitoring Market Value Share (%) and BPS Analysis by Technique, 2022-2032
Figure 123: MEA Therapeutic Drug Monitoring Market Y-o-Y Growth (%) Projections by Technique, 2022-2032
Figure 124: MEA Therapeutic Drug Monitoring Market Attractiveness by Analyte, 2022-2032
Figure 125: MEA Therapeutic Drug Monitoring Market Attractiveness by Technique, 2022-2032
Figure 126: MEA Therapeutic Drug Monitoring Market Attractiveness by Country, 2022-2032
